A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism
- 1 November 1990
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 28 (9) , 773-793
- https://doi.org/10.1016/0006-3223(90)90513-2
Abstract
No abstract availableThis publication has 101 references indexed in Scilit:
- Reduction of elevated CSF beta-endorphin by fenfluramine in infantile autismPediatric Neurology, 1987
- Failure of Naloxone to reduce self-injurious behavior in two developmentally disabled femalesApplied Research in Mental Retardation, 1986
- Blood serotonin concentrations and fenfluramine therapy in autistic childrenThe Journal of Pediatrics, 1986
- Study of fenfluramine in outpatients with the syndrome of autismThe Journal of Pediatrics, 1984
- Preliminary Observations on the Effect of Fenfluramine on Blood Serotonin and Symptoms in Three Autistic BoysNew England Journal of Medicine, 1982
- Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen Receptor Positive Breast CancerScience, 1982
- The role of the pineal gland in stressJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- ESTIMATION OF MONOAMINE AND CYCLIC-AMP TURNOVER AND AMINOACID CONCENTRATIONS OF SPINAL FLUID IN AUTISTIC CHILDREN1Neuropediatrics, 1980
- On the effect of melatonin upon human brain. Its possible therapeutic implicationsLife Sciences, 1971
- Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded childrenThe Journal of Pediatrics, 1961